Do COX-2 inhibitors give enough gastrointestinal protection?
Drenth
Joost P H
JP
Department of Gastroenterology and Hepatology, Heart Lung Centre, Radboud University Nijmegen, Medical Centre, 6500 HB Nijmegen, Netherlands. joostphdrenth@cs.com
Verheugt
Freek W A
FW
D018771:Arthralgia / Q000188:drug therapy* / Q000209:etiology; D001168:Arthritis / Q000150:complications; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004064:Digestive System; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D054328:Proton Pump Inhibitors
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D054328:Proton Pump Inhibitors